Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioids

被引:15
|
作者
Smith, Meredith Y.
Dart, Richard
Hughes, Alice
Geller, Anne
Senay, Edward
Woody, George
Colucci, Salvatore
机构
[1] Purdue Pharma LP, Stamford, CT 06901 USA
[2] Rocky Mt Poison & Drug Ctr, Denver, CO USA
[3] Columbia Univ, New York, NY USA
[4] Columbia Univ, Chicago, IL USA
[5] Univ Chicago, Chicago, IL USA
[6] Univ Penn, Treatment Res Inst, Philadelphia, PA USA
来源
关键词
abuse; interrater reliability; Poison Control Centers; prescription opioids;
D O I
10.1080/00952990600753982
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Poison Control Center (PCC) cases involving intentional ingestion, injection or inhalation of prescription opioids are a potentially valuable source of information on the abuse and misuse of these products. This study sought to validate PCC classifications of prescription opioid intentional exposure cases against clinical diagnostic criteria. 4,321 cases were reviewed. PCC-clinician concordance was good to excellent for Withdrawal, Abuse, and Suicide (kappa statistics: 0.73, 0.53, 0.48, respectively), but poor for Misuse and Intentional Unknown (Specific motive not known). Interrater reliability among clinicians was good (weighted kappa range: 0.56-0.68). Results demonstrate the degree of compatibility between PCC and standard nosologic classifications.
引用
收藏
页码:465 / 478
页数:14
相关论文
共 50 条
  • [41] Characterizing the use of extracorporeal membrane oxygenation in cases reported to a Regional Poison Control Center
    Zarate, Mary
    Tran, Stephanie
    Albertson, Timothy
    Lewis, Justin
    CLINICAL TOXICOLOGY, 2018, 56 (10) : 1032 - 1034
  • [42] Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits
    Davis, Jonathan M.
    Severtson, Stevan G.
    Bucher-Bartelson, Becki
    Dart, Richard C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 18 - 25
  • [43] Exposure to liquid detergent capsules: A study of the cases reported to the Paris Poison Center, 2011-2012
    Villa, A.
    Medernach, C.
    Arropetian, N.
    Lagrange, F.
    Langrand, J.
    Garnier, R.
    ARCHIVES DE PEDIATRIE, 2014, 21 (06): : 608 - 613
  • [44] Phencyclidine (PCP) Exposure Cases Among Young Children Reported to Five US Statewide Poison Control Center Systems, 2009-2018
    Gray, Hilary
    Obilom, Cherie
    Smollin, Craig
    Camarena-Michel, Alexa
    Calello, Diane
    Osterhoudt, Kevin
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1195 - 1196
  • [45] Analysis of Acute Pesticide Poisoning Cases Reported to the Poison Control and Drug Information Center in Palestine
    Sawalha, A. F.
    Sweileh, W. M.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 658 - 658
  • [46] Acute hydrofluoric acid exposure reported to Taiwan Poison Control Center, 1991-2010
    Wu, M-L
    Yang, C-C
    Ger, J.
    Tsai, W-J
    Deng, J-F
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2014, 33 (05) : 449 - 454
  • [47] Coordination of vigilance produced at the University Hospital of Nancy: experimentation of the transmission of the poison control center cases to the addictovigilance center of Nancy
    Barberot, Pauline
    Puskarczyk, Emmanuel
    Tournebize, Juliana
    Gibaja, Valerie
    Gillet, Pierre
    Manel, Jacques
    Kahn, Jean-Pierre
    THERAPIE, 2018, 73 (06): : 577 - 577
  • [48] Trends in the use of non-prescription medications for intentional self-poisoning: A review of data from the United States poison control centers
    Perez-Vilar, Silvia
    Apata, Jummai
    Pennap, Dinci
    Mosholder, Andrew
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 52 - 52
  • [49] A retrospective review of isolated gliptin-exposure cases reported to a state poison control system
    Darracq, M. A.
    Toy, J. M.
    Chen, T.
    Mo, C.
    Cantrell, F. L.
    CLINICAL TOXICOLOGY, 2014, 52 (03) : 226 - 230
  • [50] The Toxic Exposure Surveillance System (TESS): public health and chemical/bioterrorism Surveillance with poison center cases.
    Watson, WA
    Reid, NE
    Litovitz, TL
    PHARMACOTHERAPY, 2005, 25 (03): : 484 - 484